Other attributes
Company Operating Status
Active
Founder
Industry
Investors
NorthShore Bio is developing a silicon semiconductor-based molecular detection platform based on a proprietary nanopore technology combining synthetic, solid-state, tunable nanopores for direct single molecule detection and integrated digital output.
Timeline
No Timeline data yet.
Further Resources
No Further Resources data yet.
